Pharmaceuticals: From Discovery to Market
What does it take to get a drug to market? Who are the people making it happen in each phase of the drug development process? Where will the job growth be?
Join virologist Edward Rozhon, Ph.D., in a high-level presentation of the journey through the drug development process. You’ll get an overview of drug discovery, the FDA approval processes, and the reality of clinical trial periods.
Rozhon, instructor and chair of the Biotechnology and Clinical Trials Design and Management certificate programs at UCSC Silicon Valley Professional Education, has a long career in the biopharmaceutical industry as a contributor to the development of drugs to treat viral and autoimmune diseases, as well as several types of cancer. He’ll help you discover different career opportunities in the bioscience field based on recent advances.
- Understanding the genetic origins underlying human diseases
- Drug design (molecular modeling) and targeting (new drugs in development for SARS-CoV-2)
- Gene therapy and editing
- Immunotherapy relating to cancer treatment
- Vaccine design around recent coronavirus vaccines
- Artificial intelligence — machine learning systems in drug discovery and development
Edward Rozhon, Ph.D., has devoted his career of nearly four decades to the study of viral diseases in academia and in the biopharmaceutical industry. His areas of research include the genetics underlying the viral mechanisms of disease and drug discovery efforts to treat HIV/AIDS, herpesviruses, and several respiratory viruses.
Thursday, June 10 at 2:00pm to 3:00pm